The North America opioids market size was estimated at USD 15.28 billion in 2025 and is predicted to increase from USD 15.43 billion in 2026 to approximately USD 16.9 billion by 2035, expanding at A CAGR of 1.01% from 2026 to 2035. The market is mainly influenced by the widespread occurrence of chronic pain, cancer, and pain after surgery, all of which need effective management solutions.

North America Opioids Market Statical Scope

The North American opioids market is crucial, driven by significant medical needs and a public health crisis. Opioids such as morphine and fentanyl are seen as the best option for managing moderate to severe pain. They play an essential role in palliative care for those with terminal illnesses. The U.S. and Canada have high rates of prescription opioid use, primarily to manage chronic conditions like osteoarthritis, lower back pain, and cancer pain, prevalent in older populations. With 40-50 million surgeries annually in the U.S., opioids are widely used for post-operative pain management.

The market is shifting towards synthetic opioids like fentanyl due to their effectiveness, low production costs, and high demand, particularly in the U.S. However, rising addiction and overdose rates have created a sub-market for treatment, focusing on abuse-deterrent formulations (ADFs) and addiction medications like buprenorphine and naloxone.

Key players include Purdue Pharma, Janssen, and Hikma Pharmaceuticals, while regulatory agencies like the FDA monitor the market closely due to misuse risks. Despite challenges, there is a growing demand for safe supplies and addiction treatment, highlighting the ongoing significance of the opioid pharmaceutical market.

North America Opioids Market, By Country 2025 (%)

• U.S. – The U.S. opioids market, which includes both pain management and addiction treatment, is influenced by a mix of high rates of chronic pain, the pressing need for abuse-resistant formulations, and increasing funding for addiction treatment.
• Canada – In Canada, the opioid market and the associated public health crisis are mainly caused by the rise of dangerous, illegally made synthetic opioids, along with a background of high prescription rates.

North America Opioids Market Share, By Product, 2025 (%)

• Immediate Release/Short-acting Opioids - This segment dominates with 54% of the share because of their quick action, making them very popular for managing acute pain and short-term treatments.

• Extended Release/Long-acting Opioids - This segment is the fastest growing, with 46%, as they offer long-lasting pain relief, lower dosing frequency, and are more frequently used for chronic pain management.

• Pain Relief - This segment dominates with 68% of the share because of the common use of opioids in treating both acute and chronic pain, particularly in post-surgical care and serious illnesses.
• Anesthesia - This segment holds 12%, as opioids are significant as supplementary options in surgical anesthesia.
• Cough Suppression - This segment holds 6% of the share, since opioid-based therapies are restricted to certain conditions and are not commonly prescribed.
• Diarrhea Suppression - This segment holds 4% of the share, as opioids are selectively used for severe cough, but are not the main treatment choice.

Top Companies in the North America Opioids Market

• Purdue Pharma L.P.
• Janssen Global Services, LLC
• Hikma Pharmaceuticals PLC
• Pfizer Inc.
• AbbVie Inc.
• Sanofi
• Sun Pharmaceutical Industries Ltd.
• Mallinckrodt Pharmaceuticals
• Endo Pharmaceuticals
• Teva Pharmaceutical Industries

Segments Covered in the Report

By Product

• Immediate Release/Short-acting Opioids
  • Codeine
  • Oxycodone
  • Hydrocodone
  • Fentanyl
  • Morphine
  • Hydroxymorphone
  • Oxymorphone
  • Propoxyphene
  • Others
• Extended Release/Long-acting Opioids
  • Oxycodone
  • Hydrocodone
  • Methadone
  • Fentanyl
  • Morphine
  • Oxymorphone
  • Tapentadol
  • Buprenorphine
  • Hydromorphone
  • Others

By Application

• Pain Relief
  • Cancer pain
  • Post-Operative Care
  • Lower Back Pain
  • Orthopedic
  • Neuropathic
  • Fibromyalgia
• Anesthesia
• Cough Suppression
• Diarrhea Suppression
• De-Addiction